From:             Michael E. Coughlin, President and CEO, ScriptPro
Date:              July 26, 2002
Re:                 Food and Drug Administration (FDA), HHS, Public Meeting

Download This Section as an Acrobat File	Download the Complete Report as an Acrobat File.
50KB	3,315KB

Barcode Label Requirements for Human Drug Products
July 26, 2002, from 9 a.m. to 5 p.m.
Natcher Auditorium, Building 45
National Institutes of Health, Bethesda, MD

 

RECOMMENDATIONS FOR THE DEVELOPMENT OF A REGULATION ON BARCODE LABELING FOR HUMAN DRUG PRODUCTS, INCLUDING BIOLOGIC PRODUCTS

INDEX TO APPENDICES

APPENDIX A. - PRESCRIPTION DISPENSING PROCESS

APPENDIX B. - MULTI-VERSION DRUG PROBLEM

APPENDIX C. - DISTRIBUTOR RELABELING PROBLEM

APPENDIX D. - EXTERIOR-INTERIOR PACKAGING PROBLEM

APPENDIX E. - BARCODE AND NDC COMPLETELY DIFFERENT

APPENDIX F. - DIFFERENT 11-DIGIT NDCs PRODUCE SAME 10-DIGIT NDC

APPENDIX G. - BARCODE TRANSLATION TO NDC PROBLEM

APPENDIX H. - PACK SIZE INDICATES PROPERTY OF PRODUCT

APPENDIX I. - MULTIPLE BARCODES REFERENCE SAME DRUG

APPENDIX J. - VARIOUS TYPES OF BARCODES ON DRUGS AND MEDICAL SUPPLIES

APPENDIX K. - TWO DIFFERENT DRUGS APPEAR AS ONLY DIFFERENT PACKAGE SIZES